WuXi only CRO to make China’s list of top ten outsourcers

- Last updated on GMT

Related tags: Cro wuxi pharmatech, China

Shanghai based CRO WuXi PharmaTech has been named as one of China’s top ten outsourcing enterprises in 2008 by the country’s Ministry of Commerce.

The list, which was announced at the Second Annual China International Service Outsourcing Cooperation Conference in Nanjing late last month, features the top ten revenue generators of last year.

WuXi, which posted revenue of $256m (€183.7m) in 2008 thanks largely to gains made by the integration of AppTec into its laboratory analysis business, was the only contract research organisation (CRO) to make the top ten.

The Chinese government, which has been actively encouraging the growth of the outsourcing sector for a few years, estimated that it was worth some $1.5bn in 2008, up around 34 per cent on the previous year.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars